ARS Pharmaceuticals (SPRY) Insider Trading & Ownership $11.24 -0.54 (-4.58%) Closing price 04:00 PM EasternExtended Trading$11.72 +0.48 (+4.23%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ARS Pharmaceuticals (NASDAQ:SPRY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage40.10%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$8.92 MNumber OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$41.56 M Get SPRY Insider Trade Alerts Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SPRY Insider Buying and Selling by Quarter ARS Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/3/2025Laura ShawverDirectorSell50,000$12.31$615,500.00 1/6/2025Laura ShawverDirectorSell50,000$11.10$555,000.00 12/17/2024Sarina TanimotoInsiderSell100,000$11.67$1,167,000.00 12/13/2024Justin ChakmaInsiderSell27,272$12.06$328,900.32 12/12/2024Brian DorseyCOOSell25,000$12.30$307,500.00 12/10/2024Sarina TanimotoInsiderSell100,000$13.16$1,316,000.00 12/6/2024Justin ChakmaInsiderSell50,000$14.23$711,500.00 12/4/2024Laura ShawverDirectorSell14,772$13.75$203,115.00 12/3/2024Justin ChakmaInsiderSell45,000$13.19$593,550.00 12/2/2024Laura ShawverDirectorSell97,244$13.56$1,318,628.64 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/27/2024Justin ChakmaInsiderSell25,000$14.39$359,750.00 11/25/2024Justin ChakmaInsiderSell32,814$14.00$459,396.00 11/11/2024James E FlynnMajor ShareholderSell528,456$18.04$9,533,346.24 10/16/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 10/15/2024Sarina TanimotoInsiderSell100,000$14.88$1,488,000.00 10/8/2024Richard E LowenthalCEOSell100,000$13.83$1,383,000.00 9/18/2024Eric KarasInsiderSell10,000$14.00$140,000.00 9/17/2024Richard E LowenthalCEOSell100,000$12.93$1,293,000.00 8/26/2024Peter A ThompsonDirectorSell83,695$13.00$1,088,035.00 8/23/2024Peter A ThompsonDirectorSell69,500$13.03$905,585.00 8/21/2024Peter A ThompsonDirectorSell407,700$13.56$5,528,412.00 8/20/2024Brian DorseyCOOSell50,000$15.00$750,000.00 8/20/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 8/20/2024Richard E LowenthalCEOSell100,000$15.03$1,503,000.00 8/19/2024Eric KarasInsiderSell10,000$14.00$140,000.00 7/16/2024Richard E LowenthalCEOSell100,000$11.40$1,140,000.00 7/9/2024Sarina TanimotoInsiderSell100,000$9.62$962,000.00 6/12/2024Sarina TanimotoInsiderSell95,862$9.15$877,137.30 6/11/2024Richard E LowenthalCEOSell4,138$9.00$37,242.00 5/16/2024Sarina TanimotoInsiderSell89,096$9.06$807,209.76 5/15/2024Richard E LowenthalCEOSell5,147$9.05$46,580.35 5/14/2024Sarina TanimotoInsiderSell5,757$9.01$51,870.57 5/7/2024Sarina TanimotoInsiderSell100,000$9.34$934,000.00 4/16/2024Sarina TanimotoInsiderSell100,000$9.28$928,000.00 4/9/2024Richard E LowenthalCEOSell100,000$9.28$928,000.00 3/27/2024Ra Capital Management, L.P.DirectorBuy505,954$9.79$4,953,289.66 3/25/2024Ra Capital Management, L.P.DirectorBuy437,600$9.06$3,964,656.00 3/25/2024Richard E LowenthalCEOSell95,267$9.12$868,835.04 3/22/2024Sarina TanimotoInsiderSell2,343$9.02$21,133.86 3/21/2024Richard E LowenthalCEOSell472$9.00$4,248.00 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << 3/19/2024Richard E LowenthalCEOSell1,918$9.03$17,319.54 3/15/2024Richard E LowenthalCEOSell96,756$9.14$884,349.84 3/14/2024Sarina TanimotoInsiderSell444$9.00$3,996.00 3/13/2024Richard E LowenthalCEOSell2,800$9.00$25,200.00 2/29/2024Richard E LowenthalCEOSell3,782$9.02$34,113.64 2/28/2024Sarina TanimotoInsiderSell98,778$9.02$890,977.56 2/26/2024Sarina TanimotoInsiderSell700$9.01$6,307.00 (Data available from 1/1/2013 forward) SPRY Insider Trading Activity - Frequently Asked Questions Who is on ARS Pharmaceuticals's Insider Roster? The list of insiders at ARS Pharmaceuticals includes Alexander A Fitzpatrick, Brian Dorsey, Eric Karas, James E Flynn, Justin Chakma, Kathleen D Scott, Laura Shawver, Peter A Thompson, Ra Capital Management, L.P., Richard E Lowenthal, and Sarina Tanimoto. Learn more on insiders at SPRY. What percentage of ARS Pharmaceuticals stock is owned by insiders? 40.10% of ARS Pharmaceuticals stock is owned by insiders. Learn more on SPRY's insider holdings. Which ARS Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SPRY shares in the last 24 months: Alexander A Fitzpatrick ($144,800.00), and Ra Capital Management, L.P. ($40,348,945.66). How much insider buying is happening at ARS Pharmaceuticals? Insiders have purchased a total of 7,433,554 SPRY shares in the last 24 months for a total of $40,493,745.66 bought. Which ARS Pharmaceuticals insiders have been selling company stock? The following insiders have sold SPRY shares in the last 24 months: Brian Dorsey ($1,057,500.00), Eric Karas ($280,000.00), James E Flynn ($9,533,346.24), Justin Chakma ($2,453,096.32), Kathleen D Scott ($400,000.00), Laura Shawver ($4,969,156.75), Peter A Thompson ($7,522,032.00), Richard E Lowenthal ($8,164,888.41), and Sarina Tanimoto ($9,453,632.05). How much insider selling is happening at ARS Pharmaceuticals? Insiders have sold a total of 3,535,880 ARS Pharmaceuticals shares in the last 24 months for a total of $43,833,651.77 sold. ARS Pharmaceuticals Key ExecutivesMr. Richard Lowenthal M.B.A. (Age 58)M.S., MSMSEL, Founder, President, CEO & Director Compensation: $2.75MDr. Sarina Tanimoto M.B.A. (Age 55)M.D., Co-Founder & Chief Medical Officer Compensation: $2.47MMr. Alexander A. Fitzpatrick Esq. (Age 57)Chief Legal Officer & Secretary Compensation: $677.14kDr. Robert Bell Ph.D.Co-Founder & Chief Science OfficerMs. Kathleen D. Scott CPAChief Financial Officer1 recent tradesMr. Brian T. Dorsey M.S. (Age 55)Chief Operations Officer Mr. Daniel RelovskySenior Vice President of MarketingMr. Harris Kaplan M.B.A. (Age 72)Executive Vice President of Commercial Strategy Mr. Eric Karas (Age 51)Chief Commercial Officer Compensation: $618.61k1 recent tradesMr. Justin Chakma (Age 34)Chief Business Officer & Secretary 5 recent trades More Insider Trading Tools from MarketBeat Related Companies KRYS Insider Trading SWTX Insider Trading BHVN Insider Trading RXRX Insider Trading PTCT Insider Trading OGN Insider Trading RARE Insider Trading RNA Insider Trading ADMA Insider Trading ACLX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:SPRY) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPRY Stock Alerts